ClinicalTrials.gov term: Pulmonary Disease, Chronic Obstructive
COPD clinical trials
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-22
What changed in the last 30 days
78 trials changed in the last 30 days: 0 stopped, 32 with notable changes, 46 with minor changes only.
- Minor: ISTrainingCOPD · Isoinertial Training · COPD Trial completed
- Notable: SCOPe · Multicentric Cohort Study of Severe and Very Severe Chronic Obstructive Pulmonary Disease (COPD) in Brazil Primary completion pushed from Jul 15, 2026 to Sep 30, 2027
- Notable: HILOT · HIgh-flow Therapy in Long-term Oxygen Therapy Primary completion pushed from Dec 2027 to Dec 2028
- Notable: REACT · Reducing Exposure With Air Cleaners and Technology Recruitment opened
- Minor: COINCIDE · Cardineurovascular dIsease and Obstructive Airway Disease Start date pushed from Oct 15, 2026 to Nov 2026
- Notable: Automated Versus Manual Oxygen Titration With the EMILY.AI Device · Acute Respiratory Failure Primary endpoint(s) modified
- Notable: Continuation Study of Tilrekimig · Moderate-to-Severe Long-Term Breathing Difficulty, Known by the Medical Term of Chronic Obstructive Pulmonary Disease (COPD) to Learn About This Medicine When Used for a Long Period of Time Recruitment opened
- Minor: BIPAP on Diaphragmatic Function Trial status changed: Not Yet Recruiting → Active, Not Recruiting
- Notable: ALARMONY · Co-administration of GSK3862995B With GSK5784283 · Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Recruitment opened
- Notable: Active Cycle of Breathing Techniques · Chronic Obstructive Pulmonary Disease Recruitment opened
- Minor: GSK5784283 (Felcorekibart) Compared With Placebo · Moderate to Very Severe COPD (PERSIST COPD-1) Trial sites expanded: 7 → 11 locations
- Minor: VIGILANT · InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation Trial sites expanded: 121 → 293 locations
- Minor: PERSEPHONE · Lunsekimig Compared With Placebo · Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype Trial sites expanded: 314 → 322 locations
- Minor: COLOSSUS · Lunsekimig · Chronic Obstructive Pulmonary Disease (COPD) Trial sites expanded: 8 → 16 locations
- Notable: Outpatient Rehabilitation Programmes for Myocardial Ischemia, Heart Failure, and COPD: Satisfaction, Participation, Test Outcomes, and Factors Associated With Positive Changes in Test Results as Well as Level of Participation Recruitment opened
- Minor: COPD at a Street Level Enrollment closed, study ongoing
- Minor: Nurse-led Motivational Interviewing Intervention Targeting Sedentary Behavior · Severe COPD: An Exploratory Pilot Study Trial status changed: Enrolling by Invitation → Completed
- Minor: NMES in COPD · Multimodal Assessment of Neuromuscular Electrical Stimulation (NMES) Effects on Respiratory and Peripheral Muscles in Chronic Obstructive Pulmonary Disease (COPD) Start date pushed from Oct 2026 to Nov 2026
- Minor: Astegolimab · Chronic Obstructive Pulmonary Disease (COPD) Enrollment closed, study ongoing
- Minor: SHORE · Home Obstructive Respiratory Exacerbations Primary completion pushed from Dec 31, 2026 to Mar 31, 2027
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New sponsor entrants, last 90 days sponsors with their first trial in this area
| First posted | Trial | Sponsor | Phase |
|---|---|---|---|
| 2026-11-20 | NCT07951281 Performance of Lumetry for Arterial Carbon Dioxide (paCO2) Assessment and Chronic… | Lumetry Diagnostics GmbH new | |
| 2026-11-17 | NCT07940608 Pilot Study of an Educational Tool for Chronic Obstructive Pulmonary Disease | Prima Vard AB new | |
| 2026-11-12 | NCT07932847 Automated Versus Manual Oxygen Titration With the EMILY.AI Device in Hospitalized… | Aether Tech S.L. new | |
| 2026-11-12 | NCT07933913 Sustainable Inhaler Prescribing in Intermediate Care Units | Consorci Sanitari de l'Alt Penedès i Garraf new | |
| 2026-11-09 | NCT07924462 Chronic Respiratory Disease Participant Engagement Study | Richmond Research Institute new | |
| 2026-11-03 | NCT07914010 Reducing Exposure With Air Cleaners and Technology | University of California, Berkeley new | |
| 2026-11-02 | NCT07908381 A Study to Investigate the Efficacy and Safety of Zelicapavir Compared With Placebo in… | Enanta Pharmaceuticals, Inc new | Phase 2/3 |
| 2026-10-21 | NCT07886346 COPD Prevalence and Risk Factors Among Saudi Adults Over 18 in Taif | Taif University new | |
| 2026-10-21 | NCT07886502 Upper Airway Morphology and Physiology During Graded Positive Pressure and Nasal High… | Klinikum Dortmund Wirbelsäulenchirurgie new | |
| 2026-10-13 | NCT07871357 Urolithin A Supplementation During Pulmonary Rehabilitation in Patients With COPD | Bryan A. Ross new | Phase 2 |
Active trials by phase
| Early Phase 1 | 4 | |
| Phase 1 | 19 | |
| Phase 1/2 | 12 | |
| Phase 2 | 49 | |
| Phase 2/3 | 8 | |
| Phase 3 | 37 | |
| Phase 4 | 31 |
Not charted: 670 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Top sponsors by active trials in this area
AstraZeneca (16) · Assiut University (15) · China-Japan Friendship Hospital (11) · Henan University of Traditional Chinese Medicine (11) · VA Office of Research and Development (11) · Riphah International University (10) · GlaxoSmithKline (8) · Haisco Pharmaceutical Group Co., Ltd. (8) · Sanofi (8) · Assistance Publique - Hôpitaux de Paris (7)
Get alerts when COPD trials change
Status changes, date slips, and new sponsor entrants: detected daily, delivered to your inbox.